What are the alternative treatments to Synthroid (levothyroxine) for hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Levothyroxine (Synthroid) Remains the Standard Treatment for Hypothyroidism

Levothyroxine monotherapy should remain the standard of care for treating hypothyroidism, as there is no evidence supporting the use of alternative preparations such as desiccated thyroid hormone, combination T4/T3 therapy, or other alternatives in preference to levothyroxine. 1

Why Levothyroxine is the Gold Standard

The 2012 AACE/ATA clinical practice guidelines explicitly state that desiccated thyroid hormone should not be used for the treatment of hypothyroidism (Grade D, unanimous expert opinion) 1. This recommendation is based on the lack of systematic evidence supporting its use and concerns about variable hormone content and T4:T3 ratios depending on the brand and animal source (porcine vs. bovine) 1.

Similarly, L-thyroxine and L-triiodothyronine combinations should not be administered to pregnant women or those planning pregnancy (Grade B) due to potential for harm 1. For the general population, the 2014 American Thyroid Association Task Force concluded there is no consistently strong evidence for superiority of combination therapy over levothyroxine monotherapy in improving health outcomes 2.

Alternative Levothyroxine Formulations (Not Alternative Therapies)

If you're asking about different brands of levothyroxine rather than different medications:

  • All levothyroxine preparations contain the same active ingredient - synthetic T4 identical to that produced by the human thyroid gland 3
  • Generic levothyroxine and brand names (Synthroid, Levoxyl, Tirosint) are bioequivalent
  • The liquid capsule preparation (Tirosint) shows dissolution profiles least affected by pH changes, which may benefit patients with absorption issues 1
  • Patients should use a consistent preparation to minimize variability between refills 1

What About Persistent Symptoms on Levothyroxine?

For the 10-15% of patients with persistent hypothyroid symptoms despite biochemical euthyroidism 4:

First, Optimize Levothyroxine Therapy:

  • Target TSH of 0.3-2.0 mIU/L for 3-6 months before assessing therapeutic response 5
  • In select cases, TSH of 0.1-0.3 mIU/L (not fully suppressed) may be acceptable long-term 5
  • Ensure proper administration: take with water 30-60 minutes before breakfast or at bedtime 4 hours after last meal 1
  • Check for absorption interference from iron, calcium supplements, antacids, proton pump inhibitors 1, 3
  • Verify compliance (non-compliance is much more common than absorption problems) 1

Second, Exclude Other Causes:

  • Rule out other comorbidities causing symptoms
  • Confirm diagnosis of overt hypothyroidism - patients without clear biochemical evidence should trial discontinuation of thyroid hormone 5

Third, Consider Trial of Combination Therapy (Highly Selective):

Only after the above steps, a trial of liothyronine/levothyroxine combined therapy may be warranted through shared decision-making 5. However:

  • Evidence remains inconsistent and limited by bias 4
  • The 2014 ATA guidelines found no consistently strong evidence for combination therapy 2
  • LT3 increases adverse events compared to placebo 6
  • This should be a time-limited trial, not indefinite therapy

Interventions NOT Recommended

Avoid these alternatives:

  • Desiccated thyroid hormone (Armour Thyroid) - explicitly not recommended 1
  • TRIAC (tiratricol) - should not be used 1
  • Iodine supplementation (including kelp) in iodine-sufficient areas 1
  • Thyroid hormones for symptoms without biochemical confirmation of hypothyroidism 1

Emerging Evidence (Not Ready for Clinical Practice)

Recent research suggests potential benefits from:

  • Aerobic + resistance training combined with LT4 may reduce TSH and improve quality of life 6
  • Ginger and thyroidectomy showed improvement in fatigue in limited studies, but evidence is low quality 4
  • Yoga and Ayurvedic herbs remain preliminary with heterogeneous protocols 7

These interventions require high-quality randomized controlled trials before clinical recommendation.

Common Pitfalls to Avoid

  1. Don't switch to alternatives without optimizing levothyroxine first - most "treatment failures" are due to suboptimal dosing, poor compliance, or drug interactions
  2. Don't use desiccated thyroid - it has variable hormone content and lacks evidence of superiority
  3. Don't target specific TSH values within normal range (except in pregnancy) without clinical indication 1
  4. Don't start combination therapy in pregnant women - potential for harm 1

References

1
Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Related Questions

I am taking levothyroxine (T4) 37.5 µg; should I continue this dose, obtain thyroid function tests, or add liothyronine (T3)?
What alternative therapy should be considered for a patient whose symptoms have worsened while taking levothyroxine?
Are there natural ways to treat hypothyroidism?
What are the consequences for a diabetic patient of discontinuing thyroid hormone replacement therapy without notifying their physician?
What are the indications, dosing regimen, contraindications, and monitoring parameters for liothyronine (synthetic triiodothyronine)?
Is repeat CT angiography required after completing anticoagulant therapy for deep vein thrombosis?
Can cirrhosis cause a predominantly indirect (unconjugated) bilirubin elevation?
Does the mean corpuscular volume (MCV) decrease after one and a half years of regular blood donations, while remaining elevated in patients with megaloblastic anemia?
Will testosterone injections affect the free thyroxine (free T4) level?
In a patient taking prednisone 60 mg daily, NPH insulin 12 U, and an insulin‑to‑carbohydrate ratio of 1 U per 50 g carbohydrate, how should the NPH insulin dose and insulin‑to‑carbohydrate ratio be adjusted when the prednisone is tapered to 20 mg, 15 mg, 10 mg, and 5 mg?
For a patient taking prednisone 60 mg, NPH insulin 12 U, an insulin‑to‑carbohydrate ratio (ICR) of 1 U per gram of carbohydrate, and an insulin sensitivity factor (ISF) of 50 mg/dL per unit, how should the NPH insulin dose and the ICR be adjusted when the prednisone is tapered to 40 mg, 20 mg, 15 mg, 10 mg, and 5 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.